Forward Look Going Flat Most people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons. by Kris Conner Survivor Profile Breaking Down Barriers Cancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research. by Bradley Jones Hope for Cancer Health Equity Health care providers and communities are making strides toward ensuring equity in cancer treatment. by Marci A. Landsmann The Individual Sphere of Influence Can discussion of health inequities lead to actionable change? by Marci A. Landsmann A Treatment That Came Just in Time Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma. by Laurie Adami Putting the Patient in the Driver’s Seat In her new book, Cancer Support Community executive chair Kim Thiboldeaux offers advice to patients on how to steer their way through a cancer diagnosis, treatment and beyond. by Kevin McLaughlin Making Connections at the AACR Annual Meeting 2021 Attending a scientific conference as a patient advocate can be an exhausting, overwhelming and hugely rewarding experience. by Bradley Jones Building COVID-19 Vaccine Confidence Experts discussed how the cancer community can share accurate information and increase confidence in COVID-19 vaccines, both among people with cancer and the general population. by Kevin McLaughlin Chemobrain: It’s Not Your Imagination Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021. by Marci A. Landsmann Policy Matters Research Advocacy During COVID-19 Continued federal funding to support biomedical research, including cancer research, is vitally important during the pandemic. by Brandon Leonard, MA, and Marc Johnson, MPP next Cancer Talk Drug Delays Recurrence in People With Early-Stage Breast Cancer People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor. by Pamela Rafalow Grossman Open Medical Records: Pros and Cons Patients now have full access to their online medical records. What are the benefits and downsides? by Jen Tota McGivney Remote Care After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment. by Jon Kelvey Moving Away From the Maximum Tolerated Dose The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate. by Marcus A. Banks More Posts